Placental transfer of albendazole sulphoxide enantiomers in sheep

B. P.S. Capece, R. Pérez, A. Andaluz, F. Garcia, G. Castells, M. Arboix, Carles Cristòfol

Research output: Contribution to journalArticleResearchpeer-review

13 Citations (Scopus)


Albendazole sulphoxide (ABZSO) is an anthelmintic drug used in veterinary practice. Its molecule has a chiral centre in the sulphur atom and racemic formulations are always used. The kinetics of the ABZSO enantiomers in the last third of pregnancy in ewes, and the placental transfer to the fetus, were studied after a single-dose oral administration (7.5 mg/kg) of a racemic formulation. In mothers, the area under the plasma concentration-time curve (AUC) and Cmax values of (+)-ABZSO (42.4±10.5 μg/mL and 1.9±0.4 μg/mL, respectively) were higher than those of (-)-ABZSO (15.3±5.1 μg/mL and 1.0±0.3 μg/mL). The MRT values were 17.0±1.6 h for (+)-ABZSO and 13.1±1.8 h for (-)-ABZSO. Similar kinetic parameters were obtained in the fetus for both enantiomers, but the fetal concentrations were lower compared with values for the dam. The AUC ratio between (-)-ABZSO/(+)-ABZSO in the dam was 0.36 and in the fetuses 0.64, indicating a higher impairment for the (+)-enantiomer in its placental transfer to the fetus. © 2002 Elsevier Science Ltd.
Original languageEnglish
Pages (from-to)155-160
JournalVeterinary Journal
Issue number2
Publication statusPublished - 1 Mar 2002


  • Albendazole sulphoxide
  • Enantiomers
  • Fetus
  • Pregnancy
  • Sheep


Dive into the research topics of 'Placental transfer of albendazole sulphoxide enantiomers in sheep'. Together they form a unique fingerprint.

Cite this